Skip to main content

Percutaneous Needle Fasciotomy

Office-based percutaneous division of the Dupuytren cord with a 25-gauge needle under intradermal-only local anaesthesia, indicated for palpable pretendinous-cord contracture in selected primary disease.

Last clinically reviewed

1. Indications

Percutaneous needle fasciotomy is indicated for adults with whose disease has produced a fixed flexion deformity sufficient to interfere with hand function, where the operative anatomy is favourable to a percutaneous approach. The indication is defined as much by what is absent from the examination — bundle displacement, established proximal interphalangeal contracture, recurrent disease in a scarred field — as by what is present.
The clinical picture suited to needle fasciotomy combines:
  • a palpable [g:pretendinous-cord|pretendinous cord] in the palm, discrete on examination and traceable along its longitudinal axis;
  • a metacarpophalangeal-predominant contracture, with the driven principally by the metacarpophalangeal component rather than the proximal interphalangeal joint;
  • a positive or a functional impairment the patient considers worth correcting;
  • intact, mobile palmar skin overlying the cord, without dense adherence, prior scarring, or deep palmar pitting that would prejudice safe needle passage.
A pragmatic threshold for offering operative treatment of any modality remains a positive tabletop test plus patient-reported functional impairment.1 Hueston's original 1982 description framed the test as a selection tool rather than a diagnostic criterion, and contemporary practice considers it alongside the involved joints, the rate of progression, and the patient's expressed priorities; a positive tabletop test alone is no longer regarded as an automatic indication for surgery.1
The is recorded routinely.2 Needle fasciotomy performs best in Tubiana stage 1 to 2 disease (total flexion deformity 0–90°) where the contracting elements are accessible from the palm. Outcomes deteriorate predictably with stage 3 to 4 disease, where established proximal interphalangeal contracture, secondary capsular changes, and bundle displacement combine to limit what a percutaneous division can achieve.
Patient-preference factors that align with needle fasciotomy include:
  • a desire for rapid return to work and daily activities — most patients resume normal use within a week;34
  • explicit acceptance of the higher recurrence rate in exchange for lower up-front morbidity, with the understanding that the procedure is repeatable at recurrence;5
  • limited tolerance for the wound, the dressing burden, and the rehabilitation programme that follow ;
  • comorbidity that makes operating-room anaesthesia and tourniquet use undesirable.
Needle fasciotomy is therefore best understood as one of three operative options in a contemporary algorithm — alongside limited fasciectomy and, where licensed and available, — chosen for its pattern-of-disease and patient-preference profile rather than as a universal first-line.67

2. Contraindications

There are no specific anatomical contraindications to a percutaneous approach in favourable anatomy. The contraindications are pattern-of-disease contraindications and patient-factor contraindications.
  • [g:spiral-cord|Spiral cord] with established proximal interphalangeal contracture. The spiral cord displaces the palmarly, centrally toward the midline, and proximally — most marked at the level of the proximal phalanx, where the bundle can be displaced into a position immediately deep to the skin.12 Blind percutaneous division at this level is high-risk; needle fasciotomy is a relative contraindication when the spiral cord is the dominant disease pattern, and an absolute contraindication where the bundle position cannot be predicted.
  • Recurrent disease in a heavily scarred field. Prior limited fasciectomy or prior dermofasciectomy distorts the normal landmarks; the bundle may sit in any position relative to the scar plane. Needle fasciotomy is contraindicated in this setting unless the surgeon is confident of bundle position from preoperative ultrasound or operative experience in the specific anatomy.57
  • First-web (thumb–index commissure) disease. The spiral-equivalent and natatory-equivalent cords in this region traverse the principal arterial supply to the thumb; percutaneous division here is reserved for surgeons with specific experience in the anatomy.
  • Untreated infection at the operative site, active dermatitis, or skin breakdown over the planned needle entry.
  • Significant dermal pitting and adherence of skin to the cord without an intervening plane of subcutaneous tissue. Skin tear is the dominant complication of needle fasciotomy, and rates rise sharply where the dermis is welded to the cord.413
  • Bleeding diathesis or active anticoagulation that cannot be managed within the procedure plan. Therapeutic warfarin is not an absolute contraindication where the INR is in range and needle entry sites are limited; novel direct oral anticoagulants are managed per the patient's cardiology recommendations.
  • Inability to tolerate the awake procedure. Needle fasciotomy depends on the patient reporting paraesthesia or electrical sensation as the needle approaches a digital nerve; deep regional anaesthesia abolishes this safety mechanism and is not used.1415
A diathesis-strong primary patient — early onset, bilateral disease, ectopic disease, positive family history, male sex16 — is not in itself a contraindication to needle fasciotomy, but the prognostic information should enter the consent conversation. The recurrence trajectory after needle fasciotomy is steeper than after fasciectomy in any patient and steeper still in the strongly diathetic patient; the choice in this setting often weighs toward limited fasciectomy or, in selected cases, primary with full-thickness skin grafting.17

3. Relevant anatomy

The operative anatomy of needle fasciotomy is the , laid over the normal palmar fascial complex described by Rayan in Hand Clinics 1999 and the Journal of Bone and Joint Surgery 2007.1819 Familiarity with both — the normal architecture and its pathological reconfiguration — is what makes blind percutaneous division safe.

Normal palmar and digital fascia

The palmar fascial complex has five components — radial, ulnar, central, palmodigital, and digital. The structures relevant to needle fasciotomy are:
  • the , a triangular sheet whose longitudinal fibres condense into the of each finger;
  • the , a transverse fibre arrangement at the level of the distal palmar crease, contributing to interdigital webbing in pathological states;
  • in the digit, three structures around the neurovascular bundle: volar to the bundle, dorsal to the bundle, and the lateral digital sheet between them;
  • the spiral band running from the pretendinous band, deep to the bundle, to the lateral digital sheet — the connection that, once thickened, produces the surgically critical spiral cord.
The Groningen group has subsequently refined the segmental description into a continuous , which more accurately captures why neurovascular bundles can be displaced into the midline at the palmodigital junction.20 For the purposes of a percutaneous procedure, the practical implication is the same: the cord cannot be assumed to lie in a single plane between two stable structures.

Pathological cord pattern

McFarlane's 1974 dissection of 69 contracted fingers established the modern cord taxonomy.12 For the needle fasciotomist, the relevant distinctions are:
  • [g:pretendinous-cord|Pretendinous cord] — derived from the pretendinous band; produces metacarpophalangeal joint contracture; does not displace the neurovascular bundle. This is the cord pattern for which needle fasciotomy is most clearly indicated. McFarlane's stated principle — that the metacarpophalangeal joint is contracted only by the pretendinous cord, and the neurovascular bundle is never displaced by it — is the operative anchor for the safety of palmar percutaneous division.12
  • [g:central-cord|Central cord] — a midline distal continuation of the pretendinous cord; produces proximal interphalangeal contracture without bundle displacement.
  • [g:spiral-cord|Spiral cord] — formed from the pretendinous band, spiral band, lateral digital sheet, and Grayson's ligament. Displaces the neurovascular bundle palmarly, centrally, and proximally — most marked at the level of the proximal phalanx.1221 The spiral cord is the principal anatomical reason needle fasciotomy is not a procedure for the proximal interphalangeal joint in established disease.
  • [g:lateral-cord|Lateral cord] — derived from the lateral digital sheet; displaces the bundle medially.
  • [g:retrovascular-cord|Retrovascular cord] — runs deep to the bundle; commonly missed at primary surgery; contributes to proximal interphalangeal contracture and to incomplete correction.
  • [g:abductor-digiti-minimi-cord|Abductor digiti minimi cord] — the most distinctive anatomical exception; lies ulnar to the bundle of the little finger.

Surface anatomy and the safe zone

The operative safe zone for needle fasciotomy is the palm, proximal to the distal palmar crease, over a palpable pretendinous cord that lifts the overlying skin off the underlying flexor tendon and neurovascular structures. The puncture sites are placed:
  • at the thinnest part of the cord, where the dermis is least adherent, so that needle passage perforates only cord and not skin-to-cord adhesion;4
  • away from the palmar creases, which are the points of greatest dermal–subdermal adhesion and the most frequent sites of skin tear at the moment of cord rupture;4
  • at multiple longitudinal levels along the cord, conventionally three: a proximal palmar level, a mid-palmar level, and a distal palmar level immediately proximal to the distal palmar crease.3413
Distal to the distal palmar crease — that is, in the digit itself — the bundle lies progressively more vulnerable. Surgeons who divide cord in the digit in the awake patient do so under explicit reliance on the patient's report of paraesthesia as the needle approaches the digital nerve, with the finger held in passive extension to tension the cord and on the principle that the needle perforates a tense fibrous structure but recoils from the elastic perineurium of an undisplaced nerve.1415 Where this safety architecture cannot be relied upon — in spiral-cord disease, in recurrent disease, in the heavily scarred field — needle fasciotomy distal to the distal palmar crease is contraindicated.

4. Patient positioning

The patient is supine on a standard examination couch or operating-room trolley with the operative arm abducted onto a hand table. A reclined position (back at approximately 30–45° to horizontal) is comfortable for the patient and allows the surgeon to operate seated, with the operative hand at sternal height. No tourniquet is used.
The hand is positioned palm up with the fingers extended; an assistant or a light counter-traction strap holds the finger in passive extension throughout the procedure to maintain cord tension. Cord tension is essential: a flaccid cord cannot be reliably weakened by a fanning needle.
A standard surgical preparation is performed with chlorhexidine or povidone-iodine, and a small disposable hand drape is applied. Sterile field requirements are limited; needle fasciotomy is an office-based procedure and can be performed in a clean clinical room with appropriate hand-hygiene and instrument-sterilisation discipline.6
The instrument set is minimal: a 25-gauge hypodermic needle (one inch long is preferred, for directional and depth control), a syringe with the local anaesthetic, surgical marker, sterile gauze, and a small adhesive dressing for the puncture sites at the close of the procedure.3

5. Approach

The approach is percutaneous; there is no incision. The cord is identified by palpation with the finger held in passive extension, and its longitudinal axis is marked on the skin with a fine surgical marker. Three portal levels along the cord are then planned and marked: a proximal portal in the palm, a mid-palmar portal, and a distal portal sited immediately proximal to (and never crossing) the distal palmar crease.413
Each portal is placed:
  • at the thinnest part of the cord at that longitudinal level;
  • off the palmar creases, both transverse (proximal and distal palmar creases) and digital (the metacarpophalangeal flexion crease at the digit base);
  • at the central axis of the cord in the transverse plane — not at its radial or ulnar margin, where the digital nerves run in the digit and where the bundle's palmar position lies if it has been displaced by an unrecognised spiral component.
At each portal, 0.1 to 0.2 mL of 1 per cent lidocaine with adrenaline is injected intradermally only.1415 The subdermal tissue and the cord itself are not anaesthetised. This intradermal-only technique is the central safety architecture of the procedure: a deeper local anaesthetic deposit would obtund the patient's report of paraesthesia as the needle later approaches a digital nerve. The patient is asked, before any deeper instrumentation, to confirm intact pulp sensation in the digit being operated on.15

6. Key steps

  1. 1. Portal marking and first portal

    The cord is palpated in passive extension and its longitudinal axis is marked. The three portal levels are marked along this axis. The first (most distal) portal is sited immediately proximal to the distal palmar crease, off the crease, at the thinnest point of the cord at that level.
    A 25-gauge needle is mounted on a small (1 or 2 mL) syringe of 1 per cent lidocaine with adrenaline. Intradermal injection only, 0.1 to 0.2 mL, raising a clear skin wheal. The patient is asked to confirm intact pulp sensation in the operated digit before any deeper instrumentation.

  2. 2. Cord weakening at the first portal

    The needle is passed perpendicularly through the wheal until it abuts the cord. Resistance changes characteristically at this level: the cord feels firmer and more discrete than the surrounding subcutaneous tissue. The needle is advanced through the cord and slightly beyond, and the patient is asked again to confirm pulp sensation; loss of pulp sensation, paraesthesia, or an electrical sensation distal to the needle tip is grounds for immediate withdrawal and repositioning.1415
    The cord is then weakened at this level by three sequential mechanical actions, each performed with the finger held in firm passive extension:
    1. Perforation in a fan-shaped pattern in the transverse plane — multiple small advances and partial withdrawals of the needle within the substance of the cord, sweeping radially and ulnarly;313
    2. Side-to-side bevel motion — small longitudinal arcs of the needle bevel within the cord, using the bevel as a small cutting edge; this is the action Lermusiaux's original 1970s technique introduced to the percutaneous-fasciotomy lineage and it is what gives the procedure its distinctive cracking feel as the cord weakens;22
    3. A brief test of cord strength — controlled passive extension of the joint of interest, with the surgeon palpating the cord. If the cord begins to give, perforation continues until it ruptures audibly or palpably; if it does not give, the surgeon proceeds to the next portal rather than escalating force at the current level.
    A characteristic snap — felt through the surgeon's palpating hand on the cord and often audible in a quiet room — signals rupture. The joint visibly extends. If full extension is achieved at this level, the procedure can be concluded for that joint.

  3. 3. Mid-palmar portal

    If the joint has not extended fully after the first portal, a second portal is sited at the mid-palmar level along the marked cord axis. The intradermal injection, sensation check, and weakening sequence are repeated. Depending on cord length and disease pattern this portal alone is often the one at which the cord ruptures, particularly in pretendinous-cord disease producing a metacarpophalangeal contracture in the ring or little finger.

  4. 4. Proximal palmar portal

    The most proximal portal is sited at the proximal third of the palm, again along the cord axis, off the palmar creases. The same weakening sequence is applied. By this point the cord has been weakened at three levels, and the controlled extension manoeuvre at the joint of interest typically completes the rupture if it has not already occurred at the mid-palmar level.

  5. 5. Distal extension and confirmation

    After cord rupture, the joint is held in passive extension for several seconds to allow the cut ends of the cord to retract. Hyperextension of at least 10° is sought.3 Active and passive extension are documented.
    If a residual contracture remains — for example, a partially-corrected metacarpophalangeal joint with a separate proximal interphalangeal component — the assessment is whether the residual cord lies in the palm (potentially addressable by further palmar portals) or in the digit (where the safety architecture of the palmar approach no longer applies). The decision to continue into the digit is a separate operative decision, taken on the table, based on whether the digital cord is palpable and discrete, whether sensation in the digit remains fully intact, and whether the surgeon's experience supports digital needle work in the specific anatomy of this case.

  6. 6. Closure of the procedure

    There is no surgical closure. The puncture sites are cleaned, a small adhesive dressing is applied to each, and a soft non-restrictive bandage covers the palm. The patient is encouraged to mobilise the fingers immediately. The procedure typically takes 15 to 30 minutes per ray; multiple rays can be addressed in the same session.34

7. Closure

There is no formal closure. Each puncture site is approximately 0.5 to 1 mm in diameter and seals spontaneously; a small adhesive dressing is applied to each. A soft bandage covers the palm overnight and is removed by the patient the following day.
Where a skin tear has occurred at the moment of cord rupture — most commonly a transverse split of the dermis at a palmar crease — the tear is left to heal by secondary intention. Skin tears in this setting are typically 5 to 15 mm in length, lie at the surface only, do not communicate with cord cavity, and heal within two to three weeks without intervention.413 Where the tear is wider or deeper than this, simple closure with a single 5-0 nylon suture can be considered; there is no role for graft or flap closure in the percutaneous setting.
Skin tear is recorded on the operative note as a procedural finding, not as a complication in the consent sense — it occurs in approximately 3 to 5 per cent of fingers in the largest published series4 and is part of the procedure profile rather than an adverse event.

8. Aftercare

Immediate finger and wrist range of motion is encouraged from the end of the procedure. The patient is instructed to use the operated hand for light pain-free activities the same evening — eating, dressing, driving — and to resume normal use within the first few days as comfort allows.3
Routine post-operative splinting is not applied for metacarpophalangeal contractures.313 For proximal interphalangeal contractures where any residual extension deficit was corrected by needle fasciotomy, a volar night extension splint for several weeks is sometimes prescribed by some operators on the principle that night extension may delay re-contracture; the evidence for this practice is weak and it is not universally adopted.3
Routine referral to a hand therapist is not part of the standard pathway after needle fasciotomy.34 This is a deliberate divergence from the post-fasciectomy pathway, where formal hand therapy is the standard of care: the rationale is that needle fasciotomy produces no surgical wound and no oedema burden, and that the dominant determinant of the operative result is the operative correction, not the post-operative rehabilitation. Selective referral is appropriate where:
  • a residual stiffness disproportionate to the correction is present at one to two weeks;
  • the patient has occupational or sporting requirements for an early structured return programme;
  • the contracture was severe (Tubiana 3 or 4) and a phased re-extension protocol is wanted to consolidate the correction.
Wound check is not required unless the patient has concerns. The first scheduled clinic review is at six weeks, at which point goniometry is repeated and the corrected position is documented as the time-zero reference for recurrence per the Felici 2014 European consensus definition (passive extension deficit of more than 20° at any treated joint, in the presence of a palpable cord, compared with the value measured at six weeks to three months postoperatively).23 This is the recurrence-baseline that subsequent follow-up is measured against.
Routine clinical review is offered at six months and at one year. After this, follow-up is on demand. The patient is given a clear instruction to return at any time if a new cord becomes palpable, if the corrected position deteriorates, or if a new joint becomes affected — both because the natural history is one of progression and recurrence, and because the procedure can be repeated at recurrence with a comparable safety profile to the primary intervention.5

9. Complications

Major complications of percutaneous needle fasciotomy — those requiring open revision, nerve repair, or readmission — are uncommon. The Krefter 2017 systematic review across 113 studies pooled an overall complication rate of 18.9 per cent (95 per cent CI –5.5 to 43), driven predominantly by minor events.24 The Therkelsen 2020 register-based observational study of 3,331 treated fingers in 2,257 patients — the largest published safety dataset — reported very low rates of severe complications (tendon rupture, nerve injury, infection, ) when a specific PNF method was applied.13
The complications discussed at consent:
  • Skin tear. The dominant complication. Reported in approximately 3 to 5 per cent of fingers in the Pess single-surgeon series of 1,013 fingers4 and as high as 68 per cent in some smaller series with broader definitions.14 Almost universally minor; heals by secondary intention. Risk is highest in older patients with thin atrophic skin and in severe metacarpophalangeal contracture where the cord has lifted the dermis tight against itself.
  • Persistent or recurrent contracture. Heterogeneous figures across the literature, depending on the recurrence definition applied (§ 08). The largest comparative randomised dataset is van Rijssen 2012 — 84.9 per cent recurrence at five years (defined as ≥30° increase in ) compared with 20.9 per cent after limited fasciectomy.25 The Pess single-arm follow-up at three years documents 72 per cent retention of the metacarpophalangeal correction and 31 per cent retention of the proximal interphalangeal correction.4 These figures are not directly comparable because the definitions differ; both characterise the same broad reality, that needle fasciotomy is an effective primary correction with substantially less durable retention than fasciectomy.
  • Digital nerve injury. Rare. The Foucher 2003 series of 311 fingers reported a single nerve injury, occurring during a re-procedure; there were no nerve injuries during primary procedures across the entire series.3 The risk-bearing anatomy is the spiral cord at the proximal phalanx, where bundle displacement makes the bundle's position unpredictable.1221 Prevention rests on selection (palmar pretendinous cord only; § 02), on intradermal-only anaesthesia preserving sensation (§ 05), and on the patient's reported paraesthesia as a real-time warning.1415
  • Digital artery injury. Rare. Same anatomical setting as nerve injury; same prevention. Direct repair under loupe magnification or proceeding to open exploration is the management if it occurs.
  • Tendon injury. Exceedingly rare. The bevel-driven mechanical action divides cord but recoils from the elastic gliding flexor tendon, particularly when the patient is asked to flex actively as needle position is being checked — active flexion produces tendon glide against the needle and is registered immediately as discomfort and as a felt resistance. Reported in single-case literature as an outlier.
  • Wound infection. Less than 1 per cent. Office-based percutaneous puncture in clean conditions carries a low infection risk; standard hand-hygiene and instrument-sterilisation discipline are sufficient.
  • Complex regional pain syndrome. Less than 1 per cent across most series; the female patient and a history of complex regional pain syndrome in another limb are recognised risk factors, regardless of operative modality.

10. Evidence

The evidence base for percutaneous needle fasciotomy spans the Foucher 2003 modern-era foundational series, the van Rijssen 2012 randomised comparison with limited fasciectomy, the Pess 2012 large single-surgeon series, and the Therkelsen 2020 registry safety dataset.
The Foucher Journal of Hand Surgery (British Volume) 2003 series of 211 patients, 261 hands, and 311 fingers anchors the modern technique and the modern outcome figures.3 Postoperative gain was greater at the metacarpophalangeal joint than at the interphalangeal joint level (79 per cent versus 65 per cent), there was a single digital nerve injury during a re-procedure, and there were no infections or tendon injuries across the entire series. Recurrence at a mean 3.2-year follow-up of the first 100 patients exceeded 50 per cent; the figure is consistent with subsequent randomised data.
The van Rijssen Plastic and Reconstructive Surgery 2012 randomised trial of 111 patients (115 hands) with a minimum 30° passive extension deficit, comparing percutaneous needle fasciotomy with limited fasciectomy at five-year follow-up, is the central comparative document for the operative choice.25 Recurrence — defined here as ≥30° increase in total passive extension deficit relative to the postoperative value — was 84.9 per cent in the needle-fasciotomy arm and 20.9 per cent in the fasciectomy arm (p < 0.001). The clinically informative finding alongside the recurrence differential is that 53 per cent of patients preferred percutaneous needle fasciotomy in the event of a recurrence, a figure that grounds the patient-preference framing of the modality choice.
The Pess, Pess, and Pess Journal of Hand Surgery (American Volume) 2012 single-surgeon series of 474 patients and 1,013 fingers, with mean three-year follow-up, is the largest published primary-procedure dataset.4 Immediate postoperative correction averaged 99 per cent at the metacarpophalangeal joint and 89 per cent at the proximal interphalangeal joint; at three-year follow-up, 72 per cent of the metacarpophalangeal correction and 31 per cent of the proximal interphalangeal correction was retained. Skin tears were the dominant complication.
The van Rijssen and Werker Journal of Hand Surgery (American Volume) 2012 second paper — 30 patients and 40 fingers undergoing repeat needle fasciotomy for recurrent disease, mean 4.4-year follow-up — supports the repeatability argument that anchors the modality's selection profile: 50 per cent of patients remained recurrence-free at the mean follow-up after a repeat percutaneous procedure.5
The Therkelsen, Skov, Laursen, and Lange Acta Orthopaedica 2020 register-based observational cohort study of 3,331 treated fingers in 2,257 patients is the largest published safety dataset.13 Severe complications — tendon rupture, nerve damage, infection, amputation, reflex sympathetic dystrophy — were uncommon when a specific PNF method (Lermusiaux–Debeyre) was applied. The finding does not generalise to all percutaneous techniques but establishes a defensible safety profile for the technique as taught in the European school.
The Krefter Hand Surgery and Rehabilitation 2017 systematic review across 113 studies pooled complication rates across operative modalities for Dupuytren's disease: limited fasciectomy 17.4 per cent (95 per cent CI 11.7–23.1), percutaneous needle fasciotomy 18.9 per cent, dermofasciectomy 11.6 per cent, collagenase injection 78 per cent.24 The figures are dominated by minor events; the type of complication differs between modalities, with nerve and vessel injury concentrated after fasciectomy and skin tear concentrated after needle fasciotomy and collagenase.
The van den Berge Journal of Hand Surgery (European Volume) 2025 individual-patient-data meta-analysis is the most current synthesis: clinically relevant contracture correction is comparable across limited fasciectomy, percutaneous needle fasciotomy, and collagenase; collagenase carries the highest minor-complication burden; limited fasciectomy delivers the longest time to recurrence.6 This meta-analysis is the contemporary anchor for the position that no modality is universally first-line and that selection turns on cord pattern and patient preference.
The Räisänen DETECT trial in Annals of Internal Medicine 2024 — multicentre randomised trial across six Finnish public hospitals, 302 patients, two-year follow-up — found surgery superior to needle fasciotomy (78 versus 50 per cent success) at two years, with three-month outcomes equivalent.7 The trial reinforces the same direction of difference established by van Rijssen 2012 in a contemporary public-system setting.
Two further documents are part of the contemporary evidence furniture without changing the substantive conclusions: the Cochrane review of Rodrigues et al. 2015 remains the current Cochrane synthesis as of May 2026 and characterises much of the comparative literature as insufficient evidence;26 the BSSH HAND-2 trial closed to recruitment on 31 January 2024 with two-year follow-up to 2027 and is expected, when published, to be the largest UK comparative dataset.27
The recurrence figures across all of the above are sensitive to the recurrence definition applied; the Werker, Pess, van Rijssen, and Denkler 2012 review documented heterogeneity ranging from 0 to 100 per cent across 21 published studies depending on the definition.28 The contemporary consensus definitions are the Felici 2014 European Delphi (passive extension deficit of more than 20° at any treated joint, in the presence of a palpable cord, compared with the postoperative value at six weeks to three months)23 and the Kan 2017 international Delphi (no palpable cord required; baseline at six weeks; endpoint at one year).29 Either definition is acceptable for trial reporting; the Felici criterion is the more commonly cited in European practice.
A formal AAOS or ASSH practice guideline of comparable graded methodology to the BSSH guideline does not currently exist for Dupuytren's disease; Eaton 2011 and Rayan 2007 remain the leading US synthesis articles.1419 A specific German handchirurgische S3 Leitlinie zum Morbus Dupuytren is not currently registered with the AWMF as of search date in May 2026.
For patients — plain-language summary

What the procedure involves

Percutaneous needle fasciotomy is a small, office-based procedure to weaken the tight cord in your palm that is pulling your finger down. The cord is divided through the skin using a fine hypodermic needle. There is no cut, no stitches, and no formal hospital stay. The procedure usually takes 15 to 30 minutes per finger.
You are awake throughout. The skin over the cord is numbed with a small amount of local anaesthetic, but the deeper tissue is left with normal sensation on purpose: this is what allows you to tell the surgeon if the needle is approaching a nerve, and it is the most important safety feature of the procedure. You may feel pressure, a series of small clicks, and a sudden release as the cord gives way. You should not feel sharp pain.

What to expect immediately afterwards

You go home with a soft bandage on the hand and a small adhesive dressing over each needle puncture. You can use the hand for light tasks the same day — eating, dressing, driving home is usually possible. The bandage comes off the next morning. The puncture sites are tiny and seal themselves within a day or two.
Some patients have a small skin tear at the moment the cord ruptures, particularly if the skin is thin or if the contracture was severe. If this happens, the tear is left to heal on its own; it is rarely a problem.

The first weeks

Most patients are back to normal activities within a few days and to all activities within one to two weeks. There is no formal hand therapy programme after this procedure for most patients, and no splint is needed for routine cases. You will be reviewed in clinic at six weeks, at which point your finger position is recorded as a reference for future follow-up.

What to expect long term

Needle fasciotomy is an effective way to straighten the finger, but the cord can come back over time. Many patients have some return of the contracture within a few years. The procedure can be repeated if the cord recurs, with a comparable safety profile to the first procedure — and this repeatability is one of the main reasons patients choose this approach over a larger operation.
The choice between needle fasciotomy and a more extensive operation (limited fasciectomy) is one to make in consultation. Needle fasciotomy is the smaller intervention with the faster recovery and the higher chance of recurrence; limited fasciectomy is a larger operation with a longer recovery and a lower chance of recurrence. Neither is universally better; each is right for some patients.

When to seek attention afterwards

Contact the practice if the hand becomes swollen, red, or hot in the days after the procedure; if the operated finger becomes numb or starts to feel cold; if the puncture sites continue to bleed beyond the first hour; or if the cord returns and is causing you concern. A clinic review can be arranged at any time.

References

  1. Hueston JT. The table top test. The Hand. 1982;14(1):100-103. DOI
  2. Tubiana R, Michon J, Thomine JM. Scheme for the assessment of deformities in Dupuytren's disease. Surg Clin North Am. 1968;48(5):979-984.
  3. Foucher G, Medina J, Navarro R. Percutaneous needle aponeurotomy: complications and results. J Hand Surg Br. 2003;28(5):427-431. PubMed DOI
  4. Pess GM, Pess RM, Pess RA. Results of needle aponeurotomy for Dupuytren contracture in over 1,000 fingers. J Hand Surg Am. 2012;37(4):651-656. DOI
  5. van Rijssen AL, Werker PMN. Percutaneous needle fasciotomy for recurrent Dupuytren disease. J Hand Surg Am. 2012;37(9):1820-1823. PubMed DOI
  6. van den Berge BA, Habibi H, Dijkstra PU, et al. Outcomes of limited fasciectomy, needle fasciotomy and collagenase injection for Dupuytren's disease: a systematic review and meta-analysis of individual patient data. J Hand Surg Eur Vol. 2025;50(7):878-890. PubMed DOI
  7. Räisänen MP, Karjalainen T, Hulkkonen S, et al. Surgery, needle fasciotomy, or collagenase injection for Dupuytren contracture: a randomized controlled trial. Ann Intern Med. 2024;177(3):295-304. PubMed DOI
  8. European Medicines Agency. Xiapex (collagenase clostridium histolyticum) — Withdrawal of marketing authorisation. EMA, March 2020. 2020. Available at: https://www.ema.europa.eu/en/medicines/human/EPAR/xiapex.
  9. Medsafe (New Zealand). XIAFLEX® discontinuation — Dear Healthcare Professional letter, 28 June 2019. Medsafe, New Zealand. 2019. Available at: https://www.medsafe.govt.nz/safety/DHCPLetters/XiaflexDiscontinuation.pdf.
  10. Strömberg J, Ibsen Sörensen A, Fridén J. Percutaneous needle fasciotomy versus collagenase treatment for Dupuytren contracture: a randomized controlled trial with a two-year follow-up. J Bone Joint Surg Am. 2018;100(13):1079-1086. PubMed DOI
  11. Byström M, Ibsen Sörensen A, Samuelsson K, Fridén JO, Strömberg J. Five-year results of a randomized, controlled trial of collagenase treatment compared with needle fasciotomy for Dupuytren contracture. J Hand Surg Am. 2022;47(3):211-217. PubMed DOI
  12. McFarlane RM. Patterns of the diseased fascia in the fingers in Dupuytren's contracture. Displacement of the neurovascular bundle. Plast Reconstr Surg. 1974;54(1):31-44. PubMed DOI
  13. Therkelsen LH, Skov ST, Laursen M, Lange J. Percutaneous needle fasciotomy in Dupuytren contracture: a register-based, observational cohort study on complications in 3,331 treated fingers in 2,257 patients. Acta Orthop. 2020;91(3):330-334. DOI
  14. Eaton C. Percutaneous fasciotomy for Dupuytren's contracture. J Hand Surg Am. 2011;36(5):910-915. PubMed DOI
  15. Lange J, Therkelsen LH, Skov ST. Percutaneous Needle Fasciotomy for Dupuytren Contracture. JBJS Essent Surg Tech. 2019;9(2):e12. DOI
  16. Hindocha S, Stanley JK, Watson S, Bayat A. Dupuytren's diathesis revisited: evaluation of prognostic indicators for risk of disease recurrence. J Hand Surg Am. 2006;31(10):1626-1634. PubMed DOI
  17. Brotherston TM, Balakrishnan C, Milner RH, Brown HG. Long-term follow-up of dermofasciectomy for Dupuytren's contracture. Br J Plast Surg. 1994;47(6):440-443. DOI
  18. Rayan GM. Palmar fascial complex anatomy and pathology in Dupuytren's disease. Hand Clin. 1999;15(1):73-86. PubMed
  19. Rayan GM. Dupuytren disease: anatomy, pathology, presentation, and treatment. J Bone Joint Surg Am. 2007;89(1):189-198. PubMed DOI
  20. Malsagova AT, Zwanenburg RL, Werker PMN. New insights into the anatomy at the palmodigital junction in Dupuytren's disease: the palmodigital spiralling sheet. J Hand Surg Eur Vol. 2019;44(9):892-898. PubMed DOI
  21. Hettiaratchy S, Tonkin MA, Edmunds IA. Spiralling of the neurovascular bundle in Dupuytren's disease. J Hand Surg Eur Vol. 2010;35(2):103-108. PubMed DOI
  22. Lermusiaux JL, Debeyre N. Le traitement médical de la maladie de Dupuytren. In: In: de Sèze S et al, eds. *L'actualité rhumatologique 1979*. Paris: Expansion Scientifique Française. 1980:338-343.
  23. Felici N, Marcoccio I, Giunta R, et al. Dupuytren contracture recurrence project: reaching consensus on a definition of recurrence. Handchir Mikrochir Plast Chir. 2014;46(6):350-354. DOI
  24. Krefter C, Marks M, Hensler S, Herren DB, Calcagni M. Complications after treating Dupuytren's disease: a systematic literature review. Hand Surg Rehabil. 2017;36(5):322-329. PubMed DOI
  25. van Rijssen AL, ter Linden H, Werker PMN. Five-year results of a randomized clinical trial on treatment in Dupuytren's disease: percutaneous needle fasciotomy versus limited fasciectomy. Plast Reconstr Surg. 2012;129(2):469-477. PubMed DOI
  26. Rodrigues JN, Becker GW, Ball C, Zhang W, Giele H, Hobby J, et al. Surgery for Dupuytren's contracture of the fingers. Cochrane Database Syst Rev. 2015(12):CD010143. PubMed DOI
  27. Davis TRC, HAND-2 Study Group. A randomised feasibility trial comparing needle fasciotomy with limited fasciectomy treatment for Dupuytren's contractures. Pilot Feasibility Stud. 2020;6:7. DOI
  28. Werker PMN, Pess GM, van Rijssen AL, Denkler K. Correction of contracture and recurrence rates of Dupuytren contracture following invasive treatment: the importance of clear definitions. J Hand Surg Am. 2012;37(10):2095-2105.e7. PubMed DOI
  29. Kan HJ, Verrijp FW, Hovius SER, van Nieuwenhoven CA, Selles RW, Dupuytren Delphi Group. Recurrence of Dupuytren's contracture: a consensus-based definition. PLoS One. 2017;12(5):e0164849. DOI